Therefore, it was necessary to be vigilant that some DM patients with negative MSA/MAA developed RP-ILD although the ratio of RP-ILD was lower in this group of patients than in the MDA5+DM and ASS patients. This evidence concerns the gene IFIH1 and interstitial lung disease.